Aridis Pharmaceuticals, Inc. (ARDS)
OTCMKTS: ARDS · Delayed Price · USD
0.0010
0.00 (0.00%)
Aug 30, 2024, 4:00 PM EDT - Market closed
Aridis Pharmaceuticals Employees
Aridis Pharmaceuticals had 37 employees as of December 31, 2022. The number of employees increased by 3 or 8.82% compared to the previous year.
Employees
37
Change (1Y)
3
Growth (1Y)
8.82%
Revenue / Employee
$604,297
Profits / Employee
-$30,865
Market Cap
53.32
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
ARDS News
- 2 months ago - Aridis Provides Corporate Update - GlobeNewsWire
- 9 months ago - Aridis Pharmaceuticals Announces Adjournment of Annual Meeting of Stockholders until January 12, 2024 - GlobeNewsWire
- 10 months ago - Aridis Pharmaceuticals Announces Third Quarter 2023 Financial Results and Business Update - GlobeNewsWire
- 1 year ago - Aridis Pharmaceuticals Announces $2 Million Offering - GlobeNewsWire
- 1 year ago - Aridis Receives Agreement from the European Medicines Agency (EMA) on the Clinical Study Design and a Single Confirmatory Phase 3 Study of AR-301 - GlobeNewsWire
- 1 year ago - Aridis' AR-301 Monoclonal Antibody is Among the First Biologics to Receive FDA's Qualified Infectious Diseases Product (QIDP) Designation - GlobeNewsWire
- 1 year ago - Aridis Pharmaceuticals and Rail Vision Interviews to Air on Bloomberg TV on the RedChip Money Report(R) - Accesswire
- 1 year ago - Aridis Pharmaceuticals Announces First Quarter 2023 Financial Results and Business Update - GlobeNewsWire